The Institute for Innovation, Translation and Policy Research (ITPR) is proud to present our symposium, Drug Development – Roadmap to U.S. FDA Clinical Trial, featuring a diverse lineup of prominent speakers who are leaders and innovators in the pharmaceutical and medical fields. They will share their expertise, experiences, and visionary ideas on drug development and other medical innovations. Over 10 cutting-edge medical innovations will be showcased in this symposium, making it an essential occasion for anyone seeking inspiration and industry-leading information.

The symposium will also feature the signing of a tri-partite research collaboration agreement between HKBU, the Faculty of Medicine at Macau University of Science and Technology, and Avalon Biomedical Management Limited for a project aimed at enhancing Berberine absorption by integrating Chinese and Western medicine, marking a pivotal moment in our commitment to advancing research and innovation in the biomedical field.

Date: 23 January 2025 (Thursday)

Time:  2:30 – 6:00 PM (registration starts at 2:00 PM)

Venue: Grand Hall A, Phase 3, Hong Kong Science Park 

Language: English

 

Keynote Speakers

 

Prof. Hon Dennis Lam, JP, Adjunct Senior Investigator, HKBU Prof. Hon Dennis Lam, JP, Adjunct Senior Investigator, HKBU

 

Prof. Hon Dennis Lam, JP

Adjunct Senior Investigator, HKBU

  • UK “Top 100 Ophthalmologists” for 7 consecutive years; ranked #1 in Asia and #6 in the world in 2024
  • H-Index 85, “Top 0.05% Scholar”
Prof. Johnson Yiu-nam Lau, Adjunct Senior Investigator, HKBU Prof. Johnson Yiu-nam Lau, Adjunct Senior Investigator, HKBU

 

Prof. Johnson Yiu-nam Lau

Adjunct Senior Investigator, HKBU

  • Former senior executive at Schering-Plough/Merck
  • H-index 80
  • Led 5 novel blockbuster drugs development with global approval and 5 IND applications

  

Prof. Bian Zhaoxiang, MH, Associate Vice-President (Clinical Chinese Medicine), HKBU Prof. Bian Zhaoxiang, MH, Associate Vice-President (Clinical Chinese Medicine), HKBU

 

Prof. Bian Zhaoxiang, MH

Associate Vice-President (Clinical Chinese Medicine), HKBU

  • Director, Centre for Chinese Herbal Medicine Drug Development Limited
  • Leading Herbal Medicine Development of CDD- 2101 (U.S. FDA IND approval), CDD-2103 (China NMPA IND approval), CDD-2107 (U.S. FDA Orphan Drug Designation)

  

Speakers

 

Prof. Zhang Ge, Associate Dean (Research), Office of the Dean of Chinese Medicine, HKBU Prof. Zhang Ge, Associate Dean (Research), Office of the Dean of Chinese Medicine, HKBU

 

Prof. Zhang Ge

Associate Dean (Research) of Chinese Medicine, HKBU

Prof. Cheung Yiu Ming, Chair Professor, Department of Computer Science, HKBU Prof. Cheung Yiu Ming, Chair Professor, Department of Computer Science, HKBU

 

Prof. Cheung Yiu Ming

Chair Professor, Department of Computer Science, HKBU

  

Dr Edward Shiu Fai Liu, Adjunct Investigator, HKBU Dr Edward Shiu Fai Liu, Adjunct Investigator, HKBU

 

Dr Edward Shiu Fai Liu

Adjunct Investigator, HKBU

Dr Aik Wei Shen, Assistant Professor, Department of Chemistry, HKBU Dr Aik Wei Shen, Assistant Professor, Department of Chemistry, HKBU

 

Dr Aik Wei Shen

Assistant Professor, Department of Chemistry, HKBU